Label: information for the patient
Amoxicilina/Ácido clavulánico Viatris 500 mg/125 mg
film-coated tablets EFG
Read the label carefully before starting to take the medication,because it contains important information for you.
Amoxicilina/Ácido clavulánico Viatrisis an antibiotic that eliminates the bacteria that cause infections. It contains two active ingredients called amoxicilina and ácido clavulánico. Amoxicilina belongs to a group of medicines known as “penicilinas” that sometimes may lose its effectiveness (become inactivated). The other component (ácido clavulánico) prevents this from happening.
Antibiotics are used to treat bacterial infections and do not work for viral infections, such as the flu or a cold.
It is essential to follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medication. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not dispose of the medication through the drain or in the trash.
Amoxicilina/Ácido clavulánico Viatrisis used in children and adults to treat the following infections:
Do not take Amoxicilina/Ácido clavulánico Viatris:
Do not take Amoxicilina/Ácido clavulánico Viatris if you are included in any of the above points. Before starting treatment withthis medication, if you are unsure, consult your doctor or pharmacist.
Warnings and precautions
Inform your doctor or pharmacist before taking this medication if:
If you are unsure whether any of the above symptoms affect you, inform your doctor or pharmacist before takingAmoxicilina/Ácido clavulánico Viatris.
Your doctor may investigate the type of bacteria causing your infection. Depending on the results, they may prescribe a different presentation ofamoxicilina/ácido clavulánicoor another medication.
Be aware of the following symptoms
Amoxicilina/ácido clavulánicomay worsen existing conditions or cause serious side effects. These include allergic reactions, convulsions, and inflammation of the large intestine. Be aware of certain symptoms while takingAmoxicilina/Ácido clavulánico Viatristo reduce the risk of problems. See section4.
Blood and urine analysis
If you are having blood tests (such as red blood cell studies or liver function studies) or urine tests (to control glucose levels), inform your doctor or nurse that you are takingamoxicilina/ácido clavulánico. This is becauseAmoxicilina/Ácido clavulánico Viatrismay alter the results of these types of tests.
Other medications and Amoxicilina/Ácido clavulánico Viatris
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription and herbal medications.
Amoxicilina/Ácido clavulánico Viatris may affect the functioning of mycophenolate mofetil, a medication used to prevent organ transplant rejection.
If you are taking allopurinol (used for gout) withAmoxicilina/Ácido clavulánico Viatris, you may be more likely to experience a skin allergic reaction.
If you are taking probenecid (used for gout), your doctor may adjust the dose ofAmoxicilina/Ácido clavulánico Viatris. Concomitant use of probenecid may reduce amoxicilina excretion and is not recommended.
If you are taking anticoagulants (such as warfarin) withAmoxicilina/Ácido clavulánico Viatrisyou will need more blood tests.
Amoxicilina/Ácido clavulánico Viatrismay affect the action of methotrexate (a medication used to treat cancer, severe psoriasis, or rheumatic diseases). Penicillins may reduce methotrexate excretion and cause a potential increase in side effects.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant,consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Amoxicilina/ácido clavulánicomay cause side effects such as dizziness and convulsions, and symptoms may make you unable to drive. Do not drive or operate machinery unless you are feeling well.
This medication contains less than 1 mmolper dose of 23 mg (1 mmol) of sodium per tablet; this is, essentially "sodium-free".
Use in adults and children weighing 40 kg or more
The recommended dose is:
Use in children weighing less than 40 kg
It is preferable to treat children 6 years old or less with oral suspension ofamoxicillin/clavulanic acidor the sachets.
Ask your doctor or pharmacist for advice when administeringAmoxicillin/Clavulanic Acid Viatristablets to children weighing less than 40 kg.The tablets are not suitable for children weighing less than 25 kg.
Patients with kidney and liver problems
How to take Amoxicillin/Clavulanic Acid Viatris
The tablets have a groove that can be split to make them easier to swallow. You should take the two halves of the tablet at the same time.
If you take more Amoxicillin/Clavulanic Acid Viatris than you should
If you take too muchAmoxicillin/Clavulanic Acid, you may experience symptoms such as stomach upset (nausea, vomiting, or diarrhea) or seizures. Consult your doctor as soon as possible. Bring the packaging with you to show your doctor. You can also call the Toxicology Information Service, phone 915620420, indicating the medication and the amount taken.
If you forget to take Amoxicillin/Clavulanic Acid Viatris
If you forget to take a dose, take it as soon as you remember. Do not take the next dose too soon, wait at least 4 hours before taking the next dose. Do not take a double dose to make up for the missed doses.
If you stop taking Amoxicillin/Clavulanic Acid Viatris
Continue takingAmoxicillin/Clavulanic Acid Viatrisuntil you complete the treatment, even if you feel better. You need to take the full treatment to cure the infection. If you do not, the surviving bacteria may cause the infection to return.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Symptoms to be aware of
Allergic reactions:
Contact your doctor immediately if you experience any of these symptoms.Stop taking Amoxicilina/Ácido clavulánico Viatris.
Severe skin reactions::
Contact a doctor immediately if you experience any of these symptoms.
Colitis:
If you have intense and persistent pain in the stomach area, this could be a sign of acute pancreatitis.
DIES has been reported mainly in children taking amoxicillin/clavulanic acid. It is a certain type of allergic reaction with the main symptom of repeated vomiting (1-4 hours after taking the medication). Other symptoms may include abdominal pain, lethargy, diarrhea, and low blood pressure.
Contact your doctor as soon as possible to advise you if you experience these symptoms.
Other possible severe side effects:
Jaundice, caused by an increase in bilirubin in the blood (a substance produced by the liver) that can make the skin and the white of the eyes turn yellow.
Inflammation of the protective membrane surrounding the brain and spinal cord (aseptic meningitis).
Drastic reduction in the number of white blood cells (agranulocytosis) that can cause an increase in infections, such as sore throat, mouth ulcers, fever, etc.
Inform your doctor as soon as possible to advise you if you experience these symptoms.
Other side effects:
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect 1 in 100 people):
Side effects that may appear in your blood tests:
Rare side effects(may affect up to 1 in 1,000 people):
Unknown frequency(cannot be estimated from available data):
Other side effects that have occurred in a very small number of patients and whose exact frequency is unknown.
Side effects that may appear in your blood or urine tests:
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not store at a temperature above 25 °C. Store in the original packaging.
Do not usethis medicationafter the expiration date that appears on the boxafter CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medicines you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition ofAmoxicillin/Clavulanate Viatris
Amoxicillin, 500 mg (equivalent to 574 mg of amoxicillin trihydrate) and clavulanate, 125 mg (equivalent to 148.9 mg of potassium clavulanate).
Appearance of the product and contents of the package
The film-coated tablets are white, oval, and biconvex with a notch on both sides.
Amoxicillin/Clavulanate Viatris is available in packages with 3, 10, 12, 14, 15, 16, 20, 21, 24, 30, and 50 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer:
Sandoz GmbH.
Biochemiestrasse, 10
A-6250 Kundl
Austria
or
McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin
35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13
Ireland
For more information about this medication, please contact the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medication is authorized in the EEA member states with the following names:
Germanyamoxidura plus 500/125 mg
BelgiumAmoxiclav Mylan 500 mg filmomhulde tabletten
SpainAmoxicillin/Clavulanate Viatris 500 mg/125 mg film-coated tablets EFG
GreeceCo-Amoxiclav/Mylan επικαλυμμ?να με λεπτ? υμ?νιο δισκ?α (500+125) mg/TAB
IrelandGermentin film coated tablets 500/125
NetherlandsAmoxicilline/clavulaanzuur Mylan 500/125mg, tabletten 500 + 125mg
This leaflet was approved in April 2023
The detailed and updated information about this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.